å»è¬åå ¬è¡šãããæŽå¯
ã°ããŒãã«éºäŒæ§ãªããã£ãã¯é žå°¿è¬åžå Žãè©äŸ¡ãããŸãã US$ 358.2 Mn ã§ 2025 ãããŠå°éããäºå® US$ 494.1 Mn ã«ãã 2032, å±ç€ºäŒ 2025幎ãã2032幎ãŸã§ã®4.7%ã®ååç©å¹Žéæé·ç(CAGR)ãéºäŒæ§ãªãã¯é žå°¿çŽ ã¯ãuracil-5'-phosphateãã«ã«ããã·ã©ãŒãŒãšããŠç¥ãããé µçŽ ã®æ¬ ä¹ã«ãããŸãã§ãèªåŸçãªéå éºäŒåé害ã§ãã ãã®é µçŽ ã¯ããªããã£ãã¯é žã®åè§£ã®ããã«äžå¯æ¬ ã§ãããããã«ãã£ãŠå°¿äžã®èç©ãšçµæ¶åã«ã€ãªãããæ¬ ä¹çãçºçããå Žåã éºäŒæ§ãªããã« - ã¿ã€ãIãšã¿ã€ãIIã®2ã€ã®äž»èŠãªã¿ã€ãããããŸãã ã¿ã€ã: uraci... ãã£ãšèŠã
ã°ããŒãã«ãª cleft lip æè¡åžå Žã¯ã US$ 450.5 ã¡ãŒãã« ãåãåãã 2025幎 ãããŠå°éããäºå® US$651.0 Mn ã«ãã£ãŠ 2032å¹Žãæ··åã®å¹Žæ¬¡æé·çã§è²ã€ 2025ã2032幎(CAGR)å£è ãŸãã¯å£èã®ç¹å®ã®çµç¹ãèå ã®çºéäžã«å®å šã«çµåã§ããªãã£ããšããå·Šã¯èµ·ãããŸãã æ¡ä»¶ã¯ãå£çŽ ãã¬ã ãå£ã®å±æ ¹ãéã£ãŠã錻è ã«æ¡åŒµã§ããéå£éšãæ®ããŸãã å·Šã®æªåŠçãå·Šã®åããã³palatesã¯äŸçµŠãã¹ããŒããæ¯ç§å¥åº·ããã³ç€ŸäŒçãªstigmaã®å°é£ãåŒãèµ·ããããšãã§ããŸãã 幞ãã«ããå·Šã®åãšå£èã®æè¡ã¯ãéå»10幎éã§å€§å¹ ã«é²ãã§ããŸãã å€ç§çä¿®çãšãªãã... ãã£ãšèŠã
äžççãªçµå£æäžã«ã³ãžãçåžå Žã¯ã US$ 456.4 ã¡ãŒãã« ãåãåãã 2025幎 ãããŠå°éããäºå® US$ 612.8 ã¡ãŒãã« ã«ãã£ãŠ 2032å¹Žãæ··åç©ã®å¹Žæ¬¡æé·çã§å±ç€ºãã 2025幎ãã2032幎ãŸã§ã®4.3%ã®CAGRãåãåããçµå£ã¹ã©ãã·ã¥ãšããŠäžè¬çã«ç¥ãããŠããçµå£ã«ã³ãžãçã¯ãå£è å ã«ã³ãžãã¢ã«ãã«ã³ãªã©ã®ã«ã³ãžãçèçš®ã«ãã£ãŠåŒãèµ·ããããçèææçãæããŸãã ããã¯å ç«æåãšå ç«æåã®äž¡æ¹ã®å人ã«åœ±é¿ãäžããæãäžè¬çãªäžåè¡¡çèææçã®äžã€ã§ãã ããå ç«æ¬ ä¹çãŠã€ã«ã¹/å ç«æ¬ ä¹ççå矀(HIV/AIDS)ãç³å°¿ç ãããæ²»çãã³ã«ãã³ã¹ããã€ããŸãã¯æ... ãã£ãšèŠã
äžççãªNPHP5ã®retinalã®åçã®åŠçœ®ã®åžå Žã®ãµã€ãºã¯éããããšãæåŸ ãããŸã US$ 133.3 ãã 2032 ãŸã§ US$ 15.8 2025幎ã®Mnã35.6%ã®ååç©å¹Žéæé·ç(CAGR)ãå±ç€º äºå ±æéäžãNPHP5ã®ç¶²èã®åçã¯ãé²è¡æ§ããžã§ã³ã®æå€±ãåŒãèµ·ãããŸãã§ãç¶æ¿ãããç¶²èçã§ãã NPHP5éºäŒåã®å€ç°ã«ãã£ãŠåŒãèµ·ããããçŒã®å å容äœã·ãªã¢ã®æ§é ãšæ©èœãç¶æããã®ã«åœ¹ç«ã¡ãŸããã°ããŒãã«NPHP5ã¬ããã«ã»ããžã§ãã¬ãŒã·ã§ã³ã»ããªãŒãã¡ã³ãã»ããŒã±ããåã¢ã¡ãªã« NPHP5ã®æå€§ã®åžå Žã§ããããšãæåŸ ãããŠããŸã ã¬ãã£ãã« 2025幎ã®åžå Žã·ã§ã¢ã®43.7... ãã£ãšèŠã
äžçã®ãããããããã³å¿æž©è£œååžå ŽèŠæš¡ã¯è©äŸ¡ããããšæšå®ãããŸã US$ 3.91 Bn ã§ 2025 ãããŠå°éããäºå® US$ 7.01 ã«ãã£ãŠ 2032, å±ç€º ååç©å¹Žéæé·ç(CAGR) 8.7% ãã 2025幎ïœ2032幎ã°ããŒãã«ããªãŒããã£ãã¯ãããŒã¢ã¯ãŒã 補ååžå Ž å°åçæŽå¯åã¢ã¡ãªã« äžçã®åçã®44.6%以äžãå ããäžççãªããªãŒããããããã³å¿æž©è£œååžå Žãæ¯é ããŸãã 倧å£åžå Žã·ã§ã¢ã¯ããããã®ææç©ãããããã«ã¹ã±ã¢è£œåã«å¯Ÿããæèã®å¢å ãå°åã«ãããäž»èŠãªæ¥çã®éžæã®ååšãªã©ã®èŠå ã«ãããã®ã§ãã ã¢ã¡ãªã« ããã ææè ã¯ããããã®å¹žçŠã確ä¿ãããããã±ã¢ã«ãŒ... ãã£ãšèŠã
äžççãªã¢ã·ã³ããã¯ã¿ãŒèºçã®æ²»çè¬åžå ŽèŠæš¡ã¯å°éãããšäºæ³ãããŸã US$ 1,076.0 ãã 2032, US$ 725.1 2025幎ã®Mnã¯ã5.8%ã®CAGRãå±ç€ºããŸã äºå ±æéäžãAcinetobacter pneumoniaã¯ãAcinetobacter bacteriumã«ãã£ãŠåŒãèµ·ããããäžéåŸ³ãªææçã§ãã ãããã®çްèã¯ãããŸããŸãªãã«ã¹ã±ã¢é¢é£ã®ææçãåŒãèµ·ããå¯èœæ§ããããäžççã«éèŠãªç åäœãšããŠæ°èããŠããŸãã çŸåšãAcinetobacter pneumoniaãæ²»çããããã®æ²»çãªãã·ã§ã³ãéãããŠããŸããã°ããŒãã«ã¢ã·ã³ããã¯ã¿ãŒèºçæ²»çåžå Ž-å°åæŽ... ãã£ãšèŠã
äžçã®ã¹ãã³ ã±ã¢ã®è£è¶³ã®åžå Žã®ãµã€ãºã¯è©äŸ¡ãããŸãã US$ 15.21 ãã 2025幎ã®Bn ãããŠæåŸ ããã ãªãŒã US$ 26.57 ã«ãã£ãŠ 2032, æé· ååç©å¹Žéæé·ç(CAGR) 8.3% 2025幎ïœ2032幎ã¹ãã³ã±ã¢ãµããªã¡ã³ã ããŒã±ããã»ãªãŒãžã§ãã«ã»ã€ã³ãµã€ãåç±³ã¯ãã°ããŒãã«ã§åªå¢ãªå°åãšããŠç¢ºç«ããŸãã ã¹ãã³ 40.8%ã®ã±ã¢ãµããªã¡ã³ãåžå Žã ç±³åœãç¹ã«ãæ¶è²»è ãšé«ãäœ¿ãæšãŠæåŸã¬ãã«ã®å¥åº·æèãé«ãããããæå€§ã®åžå Žã·ã§ã¢ã®ã¢ã«ãŠã³ãã ç³å°¿ç ã®ã¹ã±ãžã¥ãŒã«ãšçžãŸã£ãŠããŸããŸã座ã£ãã©ã€ãã¹ã¿ã€ã«ã¯ãæ¯æ¥ã®ã¹ãã³ã±ã¢ã®ã«ãŒãã³ãè£å®ã§ããæ é€è£å©é£... ãã£ãšèŠã
äžçã®ã¢ããªçå矀(MPS-IV)å»è¬ååžå ŽèŠæš¡ãæåŸ ããã 2025幎 US$ 1.9 Mn ãã 2032 幎ãŸã§ã® US$ 4.4 Mn ã§ãååç©ã®å¹Žéæé·ç (CAGR) ã 12.7% ã«å±ç€º äºå ±æéäžãã ã³ããªç³è³ªçã¿ã€ãIV(MPS IV)ãšãåŒã°ããã¢ããªçå矀ã¯ãé害ã®ããéçºãšçã身é·ãç¹åŸŽãšãããŸããªéºäŒç ã§ãã ããã¯ã°ãªã³ãµããã°ãªã«ã³ã®åè§£ã®ããã«èŠæ±ãããé µçŽ N-acetylgalactosamine-6ã¹ã«ãã¡ã¿ãŒãŒã®æ¬ ä¹ã«ãã£ãŠåŒãèµ·ããããã MPS IVã®çŸåšã®æ²»çãªãã·ã§ã³ã¯ãçç¶ç®¡çãšãµããŒãã«éãããŸã æ¡çšæ å ±ãåãåããäžçã®Morquioã·... ãã£ãšèŠã
äžççãªãã£ãã«ç ã®æ²»çè¬åžå ŽèŠæš¡ã¯å°éãããšäºæ³ãããŸã US$ 160.2 Mn ãã 2032 US$ 145.3 2025幎ã®Mnã1.4%ã®ååç©å¹Žéæé·ç(CAGR)ãå±ç€º äºå ±æéäžãç ç©¶éçº(ç ç©¶éçº)ã¯ãæ²»çã®ããã®èšåãæäŸããéå®³ã®æ²»çã®ããã®èŠæ±ã®å¢å ãåžå Žã®æé·ãé«ããããã«æåŸ ããããã€ãªãã¯ãããžãŒããã³è£œè¬äŒç€Ÿã«ããæŽ»åãã°ããŒãã«ãã£ãã«ç ã®æ²»çè¬åžå Ž - å°åæŽå¯åã¢ã¡ãªã« 2025幎ã®åžå Žã·ã§ã¢ã®43.7%以äžãå ãããäºæž¬æéäžã«ãã£ãã«ç æ²»çåžå Žã®ããã®æå€§ã®åžå Žã§ããããšãæåŸ ãããŸãã åã¢ã¡ãªã«å°åã¯ãè€æ°ã®ããã補è¬äŒç€Ÿãšå€§èŠæš¡ãªå»çè²»ã®ååšã§... ãã£ãšèŠã
äžççãªã¢ã©ã³ã»ãã«ã³ãã³ã»ãã¬ãŒçå矀(AHDS)(MCT8æ¬ ä¹)åžå ŽèŠæš¡ãæåŸ ããã US$ 20.8 ã«ãã£ãŠ 2032, US$ 14.1 ãã 2025幎ã®Mnã¯ã5.7%ã®æ··åç©ã®å¹Žæ¬¡æé·ç(CAGR)ãå±ç€ºããŸã äºå ±æéäžãAllan-Herndon-Dudleyçå矀(AHDS)ã¯ãMCT8éºäŒåã®å€ç°ã«ãã£ãŠåŒãèµ·ãããããŸããªéºäŒçé害ã§ãã ãããã®å€ç°ã¯ãè¡è³ã®éå£ãæž¡ãç²ç¶è ºãã«ã¢ã³ã®èŒžéãæãªãçµæããããããŸãã AHDSã®çŸåšã®æ²»çæ³ã®éžæè¢ã¯éãããŠãããçç¶ã®ç®¡çãç®æããŠããŸãã æ²»çã®æåã®ã©ã€ã³ã¯ç²ç¶è ºãå«ã¿ãŸã ãã«ã¢ã³è£å çæ³ Triiodoth... ãã£ãšèŠã
ã°ããŒãã«ãã¢ãã©ã³ã¹ãã©ã³ãã·ã¹ãã åžå ŽèŠæš¡ãæåŸ ããã US$ 44.24 ã«ãã£ãŠ 2032, US$ 11.25 ãã 2025幎ã®Bnã21.6%ã®ååç©å¹Žéæé·ç(CAGR)ãå±ç€º äºå ±æéäžã䜿çšããã2ã€ã®äž»èŠãªã¿ã€ãã®ãã¢ãã©ã³ã¹ãã©ã³ãã·ã¹ãã ããããŸã - 濟éãŠãããç§»æ€(FUT)ãšæ¿ŸèãŠãããæœåº(FUE)ãFUTæè¡ã§ã¯ãæ¯å°èãå«ãç®èã®ã¹ããªããã¯ãé«ªã®æé·ãæä¹ çã§ããé ç®ã®åŸãããå€ç§çã«é€å»ãããŸãã ã¹ããªããã¯ããã®åŸã ãã€ã¯ãã¹ã³ãŒã å1ã4åã®æ¯ãå«ã濟èãŠãããã«ã 濟èãŠãããã¯ãã¹ã«ã«ãã®ç¹æ®é åã§ãã³ãããŒã«ã«ãã£ãŠäœãããå°ããªåéã«... ãã£ãšèŠã
äžççãªçްèã®æµžéã®ãããããåžå Žã®ãµã€ãºã¯éããããšãæåŸ ãããŸã 2025幎ã®US $ 4.2 Bnãã2032幎ãŸã§ã®US $ 12.16 Bnã¯ã16.4%ã®CAGRãå±ç€º äºå ±æéäžã现è貫éãããã(CPP)ã¯ã现èèã貫éããã¿ã³ãã¯è³ªãsiRNAãããç²åãªã©ã®è²šç©ã现èã«èŒžéããããšãã§ããçãããããã§ãã 圌ãã¯ç æ°ã®æ²»çã«ãããæ²»çäžã®ã¢ããªã±ãŒã·ã§ã³ã®ããã®éèŠãªçŽæã瀺ããŠããŸãã äž»ã«CPPã®3ã€ã®ã¿ã€ãããããŸã: cationic/amphipathic CPPsãçæ°Žæ§CPPsããã³chimeric CPPsãCationic/amphipathic(ã«ããª... ãã£ãšèŠã
äžççãªæ¯ç§çšæŽå€ã®ã¿ãã¬ããã®åžå Žã®ãµã€ãºã¯éããããšãæåŸ ãããŸã US$ 668.1 ã«ãã£ãŠ 2032, US$ 379.9 ãã 2025幎ã®Mnã8.4%ã®ååç©å¹Žéæé·ç(CAGR)ãå±ç€º äºå ±æéäžãæ¯ã®ã¯ãªãŒãã³ã°ã®ã¿ãã¬ããã¯æ¯ããããã«ãã磚ãã®ãå©ããããã«èšèšãããŠããå£é å¿é ãããã¯ãã§ãã äž»ã«2çš®é¡ã®ãã³ã¿ã«ã¯ãªãŒãã³ã°ã¿ãã¬ãããå©çšå¯èœã§ã - 宿çãªãã¯ã€ããã³ã°ã 宿çãªæ¯ã®ã¯ãªãŒãã³ã°é ã«ã¯ãçé žã«ã«ã·ãŠã ãçé žãããªãŠã ãªã©ã®ç 磚å€ãå«ãŸããŠãããæ©æ¢°çã¹ã¯ã©ãäœçšã«ããæ¯ããæ±ããç³èãåãé€ããŸãã ãããã¯åºæ¬çãªå£é è¡çãç¶æããããã«æ... ãã£ãšèŠã
äžçã®å¿è¡ç®¡ã®å¥åº·ã®è£è¶³ã®åžå Žã®ãµã€ãºã¯éããããšãæåŸ ãããŸã US$ 19.74 ã«ãã£ãŠ 2032, US$ 11.98 ãã 2025幎ã®Bnã7.4%ã®CAGRãå±ç€º äºå ±æéäžãå¿èã®å¥åº·ããã³åŸªç°ãæ¯ããããã«æå³ãããŠããå¿èã®å¥åº·ã®è£è¶³ã¯ããŸããŸãªãããã¯ããå«ãã§ããŸãã äžè¬çã«äœ¿çšããããµããªã¡ã³ãã®ããã€ãã®äž»èŠãªã¿ã€ãããããŸãã Omega-3èèªé žãµããªã¡ã³ããEPA(eicosapentaenoic acid)ãšDHA(docosahexaenoic acid)ãå«ããã®ãããªã°ãªã»ãªãã¬ãã«ãäœäžãããççãæžããã®ã«åœ¹ç«ã€ããšã瀺ãããŠããŸãã Coenz... ãã£ãšèŠã
äžççãªèªå·±å ç«å€åœéçå矀ã¿ã€ã1åžå ŽèŠæš¡ãæåŸ ããã US$ 362.8 Mn ãã 2032, US$ 289.1 2025幎(æå20幎)ã«CAGRãå±ç€º äºå ±æéäžãAutoimmune polyglandularã·ã³ãããŒã ã¿ã€ã1(APS1)ã¯ãAutoimmune polyendocrinopathy-candidiasis-ectodermalãã€ã¹ãããã£ãŒ(APECED)ãšãåŒã°ããAutoimmuneã¬ã®ã¥ã¬ãŒã¿(AIRE)éºäŒåã®å€ç°ã«ãã£ãŠåŒãèµ·ãããããŸããªmonogenicç¡ç§©åºã§ããäžçã®Autoimmuneã®å€è§çãªã·ã³ãããŒã ã®ã¿ã€ã1ã®åžå Ž-å°åæŽå¯åã¢... ãã£ãšèŠã
äžçã¢ã³ãããŒãåžå ŽèŠæš¡ãæåŸ ããã 2025幎ã®US $ 3.32 Bnãã2032幎ãŸã§ã®US $ 5.69 Bnã8.0%ã®CAGRãå±ç€º äºå ±æéäžãã¢ã³ãããŒãåžå Žã¯ãæ¯ãè¬ç©ã®åœ±é¿ã察æããããã«äœ¿çšãããå»è¬å補åã§æ§æãããŠããŸãã äž»ã«2çš®é¡ã®ã¢ã³ããããããããŸã:ååŠãšçç©åŠã ååŠç©è³ªã¯ãéåžžãæ¯çŽ ã«çžãããå容äœãµã€ããçµåãŸãã¯ãããã¯ããããšã«ãã£ãŠåããŸãã ãããã¯ååŠåå¿ãéããŠææ¯ç©è³ªãäžåããŸãã å ±éã®ååŠåç¹ã¯ã¢ã»ãã¢ãããã§ã³ã®æ¯ã®ããã®ãªããªã€ãã®éå°æåããã³ã¢ã»ãã«ã·ã¹ãã€ã³ã®ããã®naloxoneãå«ãã§ããŸãã çç©ç§åŠ äœãæ¯ã®å¹æã®ã... ãã£ãšèŠã
ã°ããŒãã«ã¯ãŒã¯ã¢ãŠããµããªã¡ã³ãåžå ŽèŠæš¡ãæåŸ ããã US$ 47.87 Bn ãã 2032, US$ 22.91 2025幎ã®Bnã11.1%ã®ååç©å¹Žéæé·ç(CAGR)ãå±ç€º äºå ±æéäžãã¯ãŒã¯ã¢ãŠããµããªã¡ã³ãæ¥çã¯ã人ã ãèªåã®ãã£ãããã¹ç®æšãéæãã圌ãã®ãã¬ãŒãã³ã°ã«ãŒãã³ãé«ããã®ãå©ããããšãç®çãšããå¹ åºã補åãæäŸããŠããŸãã äžè¬çã«ããµããªã¡ã³ãã¯åºãåé¡ããããšãã§ããŸã ã¿ã³ãã¯è³ª ãµããªã¡ã³ãããã¬ã¯ãŒã¯ã¢ãŠããµããªã¡ã³ããããã³äœéå¢å /æå€±ãµããªã¡ã³ããã¿ã³ãã¯è³ªãµããªã¡ã³ãã¯ãæã人æ°ã®ãããã¬ãŒãã³ã°ãµããªã¡ã³ãã®äžã€ã«ãªãããã«æé·ããŸããã 圌... ãã£ãšèŠã
äžççãªDupuytrenã®ç æ°ã®åžå Žã®ãµã€ãºã¯ã§è©äŸ¡ãããŸã US$ 4.98 ã§ 2025 ãããŠå°éããäºå® US$ 6.91 ã«ãã£ãŠ 2032, ååç©å¹Žéæé·çã§æé· (CAGR) ã® 2025幎ãã2032幎ãŸã§ã®4.8%ãDupuytrenã®ç æ°âéå€ç§ããã³å€ç§ã®ããã®åŠçœ®ã®2ã€ã®äž»èŠãªã¿ã€ãããããŸãã éå€ç§çåŠçœ®ã¯éã® fasciotomyãHermanase ã® clostridium Histolyticum (CCH) ã®æ³šå ¥ããã³æŸå°ç·çæ³ãå«ãã§ããŸãã éã® fasciotomy 㯠fascia ã®å¯ãªã³ã©ãŒã²ã³ãç Žå£ããã®ã«éã䜿çšããŸãã ããã¯æã®å... ãã£ãšèŠã